Embla Medical hf.
OSSFF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.92B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.92 Billion |
|---|---|
| Enterprise Value | $2.38 Billion |
| Earnings per Share | $0.2 |
| Beta | 0.46 |
| Outstanding Shares | 425,252,638 |
Return
| Return on Equity | 10.24% |
|---|---|
| Return on Assets | 5.49% |
| Return on Invested Capital | 10.45% |
Valuation & Multiples
| P/E Ratio | 17.98 |
|---|---|
| PEG | 798.48 |
| Price to Sales | 2.26 |
| Price to Book Ratio | 2.26 |
| Enterprise Value to Revenue | 2.39 |
| Enterprise Value to EBIT | 16.94 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.6 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 20, 2026
EPS Estimate
$0.07
Consensus analyst estimateRevenue Estimate
$254.53 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 2, 2027
EPS Estimate
$0.07
Consensus analyst estimateRevenue Estimate
$271.80 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Embla Medical hf.
4,500 employees
CEO: Sveinn Sölvason
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bra...